Molecular Vaccines

From Prophylaxis to Therapy - Volume 2

  • Matthias Giese

Table of contents

  1. Front Matter
    Pages i-xxviii
  2. Noninfectious and Noncancer (NINC) Vaccines

    1. Front Matter
      Pages 449-450
    2. Hiroyuki Sasamura, Tasuhiko Azegami, Hiroshi Itoh
      Pages 451-461
    3. Sara Andrade, Marcos Carreira, Felipe F. Casanueva, Polly Roy, Mariana P. Monteiro
      Pages 463-476
    4. Sandeep Kumar Gupta
      Pages 477-488
    5. Sandra Scheiblhofer, Josef Thalhamer, Richard Weiss
      Pages 489-501
  3. Adjuvants and Nanotechnology

    1. Front Matter
      Pages 517-518
    2. Xinyuan Chen, Mei X. Wu
      Pages 519-525
    3. Jesús Arenas
      Pages 527-536
    4. Jaroslav Turánek, Josef Mašek, Michal Křupka, Milan Raška
      Pages 561-577
    5. Amit K. Goyal, Goutam Rath, Basant Malik
      Pages 579-601
    6. Carlos Gamazo, Juan M. Irache
      Pages 603-622
    7. Guro Gafvelin, Hans Grönlund
      Pages 623-631
    8. Mirjam Kool, Bart N. Lambrecht
      Pages 633-642
    9. Philipp Heller, David Huesmann, Martin Scherer, Matthias Barz
      Pages 643-671
  4. In Silico and Delivery Systems

    1. Front Matter
      Pages 673-675
    2. Christine Maritz-Olivier, Sabine Richards
      Pages 677-696
    3. Ryan F. Donnelly, Sharifa Al-Zahrani, Marija Zaric, Cian M. McCrudden, Cristopher J. Scott, Adrien Kissenpfenning
      Pages 697-715
    4. Anthony J. Hickey, Herman Staats, Chad J. Roy, Kenneth G. Powell, Vince Sullivan, Ginger Rothrock et al.
      Pages 717-726
    5. Martin J. D’Souza, Suprita A. Tawde, Archana Akalkotkar, Lipika Chablani, Marissa D’Souza, Maurizio Chiriva-Internati
      Pages 727-741
    6. Aditya Pattani, Prem N. Gupta, Rhonda M. Curran, R. Karl Malcolm
      Pages 743-752
    7. Pirouz Daftarian, Paolo Serafini, Victor Perez, Vance Lemmon
      Pages 753-766
    8. Maria Gomes-Solecki
      Pages 767-779
    9. Mattia Ronchetti, Michela Battista, Claudio Bertacchini, Ruggero Cadossi
      Pages 781-791
    10. Emanuela Bartoccioni
      Pages 793-802
  5. Patenting, Manufacturing, Registration

    1. Front Matter
      Pages 803-805
    2. Stacey J. Farmer, Martin Grund
      Pages 807-821
    3. Markus Hilleringmann, Björn Jobst, Barbara C. Baudner
      Pages 823-837
    4. Bettina Klug, Patrick Celis, Robin Ruepp, James S. Robertson
      Pages 845-850
  6. Back Matter
    Pages 867-870

About this book


This title discusses all aspects of non-infectious and non-cancer– so called NINC – vaccines. Hypertension, diabetes and allergy vaccine development are referred to as well as the use of adjuvants and nanotechnology in vaccine development. The way of novel vaccines from bench to preclinical to clinical studies and launch to the market under EMEA (European Medicines Agency) and FDA (Food and Drug Administration) guidelines are described in-depth. Practical perspectives of patentability of vaccines are discussed. The book is therefore of interest for researchers and clinicians engaged in vaccine development and molecular vaccine application.


cell vaccines delivery systems prophyalxis and therapy vaccine adjuvants vaccine tools

Editors and affiliations

  • Matthias Giese
    • 1
  1. 1.Institute for Molecular VaccinesHeidelbergGermany

Bibliographic information

Industry Sectors
Health & Hospitals